Human interleukin 1/$ (IL-1B) is synthesized as an inactive precursor that is cleaved by IL-1 converting enzyme (ICE) between Asp 116 and Ala 11y to form COOH-terminal mature IL-1/3 and NH2-terminal IL-1B propeptide. Little is known about the fate of the NH2-terminal cleavage product. In this study, human recombinant (hr)IL-1/3 propeptide (amino acids 2-116) was produced and used to prepare specific antibodies which do not recognize mature human IL-1B. These anti-propeptide antibodies were used for immunoprecipitation of biosynthetically labeled proteins from lipopolysaccharide-stimulated human monocytes. Analysis of immunopredpitates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography revealed that these antibodies recognize precursor IL-I~ and two unique proteins: one migrating at 17.5 kD and one at 14 kD. The larger of these two proteins has a migration nearly identical to that of the recombinant IL-1/3 propeptide, and most likely represents naturally derived propeptide. The protein migrating at 14 kD may result from a second cleavage by ICE, between Asp 27 and Gly 2s. These proteins accumulate intracellularly and extracellularly during pulse-chase experiments, and therefore represent stable products of precursor IL-1B cleavage.
H uman (hlblB) 1 IL-IB is synthesized as a 35-kD inactive precursor protein (1) (2) (3) (4) and is cleaved to release the COOH-terminal portion of the molecule, mature 17.5-kD IL-1/3, which possesses all the known activities of IL-1B. Precursor IL-1B may be cleaved by a variety of proteases (3, 4) to give products with partial activity, but full activity is produced only by cleavage between Asp 116 and Ala tit by the newly discovered IL-1B converting enzyme (ICE) (5, 6) . Stimulated human monocytes synthesize large amounts of both precursor IL-1B and ICE (7, 8) , and produce most of the circulating mature IL-1B present in humans.
Ahhough mature IL-1/3 has been the subject of exhaustive research, surprisingly little attention has been paid to the NH2-terminal product of precursor IL-1B cleavage, the IL-1/3 propeptide. One previous study using antibodies directed against short synthetic peptides from the propeptide region (9) failed to demonstrate the presence of intact propeptide in human monocytes induced to synthesize and process ILlB. Other studies of IL-1B processing (10) (11) (12) (13) (14) have used antibodies made against mature IL-1B or peptides from the 1Abbreviations used in this paper: hr, human recombinant; ICE, IL-1B converting enzyme; hlL-1/3, human interleukin-lO; IPTG, isopropyhhiogalactoside; MBP, maltose binding protein; PGS, protein G-Sepharose.
tical to the published sequence (17) was obtained. This clone expressed a fusion protein consisting of the maltose binding protein (MBP) of E. coli, the factor Xa cleavage site, and II.-l~ propeptide (amino acids 2-116). (The NH2-terminal amino acid residue of natural precursor IL-1/3 is not known. We chose to omit the NH2-terminal methionine, because the NH2-termini of most cytosolic proteins with alanine as the second amino acid are posttranscriptionally modified by cleavage of methionine [18] . In any event, this decision is not relevant to the results of this paper.)
Synthesis of the fusion protein (MBP-II~I/~ propeptide) was induced by treatment of bacterial suspension with 3 mM isopropylthiogalactoside (IFIG) for 2 h. The bacteria were collected by centrifugation, and bacterial extract was prepared by resuspension in lysis buffer (15 mM sodium phosphate, 30 mM NaC1, 25 mM benzamidine, I mM PMSF, 1 mM EDTA, 0.2% Tween-20, pH 7.3) containing 4 mg/ml lysozyme (Boehringer Mannheim Biochemicals, Indianapolis, IN), followed by sonication. The sonicated suspension was then brought to 0.5 M NaC1, and 5 #g/ml DNAase-free KNAase was added. After removal of particulate material by centrifugation at 50,000g for 30 rain at 4~ the extract was applied to amylose resin (New England Biolabs). The resin was washed with 10 volumes of 20 mM sodium phosphate, 200 mM NaC1, i mM PMSF, pH 7.4, and fusion protein was eluted with 10 mM maltose in 20 mM "Iris, 100 mM NaC1, pH 8.0. When indicated, fusion protein was digested overnight at 4~ with 1 #g of Factor Xa protease (New England Biolabs) per 100 #g of fusion protein, to produce MBP and IL-lfl propeptide.
Amino Acid Sequencing. Fusion protein was concentrated using
Centricon-10 ultrafiltration device (Amicon Corp., Beverly, MA), digested with Factor Xa, electrophoresed on a 14% polyacrylamide SDS gel (19) , and transferred to a PVDF membrane. The band corresponding to IL-I~ propeptide was cut out and analyzed by NH2-terminal amino acid sequencing using a pulse liquid-vapor phase protein sequencer (model 477A; Applied Biosystems Inc., Foster City, CA).
Antibodies. Rabbit anti-human rlL-1/5 (mature IL-I~, IgG fraction, was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Antibodies against IL-1/~ propeptide were produced as follows: rabbits were first immunized with 500 #g of MBP-IL-lfl propeptide fusion protein in CFA. For subsequent immunizations, factor Xa digests of fusion protein were separated by SDS-PAGE on 1.5-mm-thick gels. To rapidly visualize protein bands, gels were soaked in distilled water at 23~ for 15 min, and then in 2 M KC1 at 4~ for 15 rain. The band corresponding to Ibl/3 propeptide (seen as cloudy against a dear background) was cut out and electroeluted, and then emulsified in IFA. The antiserum produced in this manner recognized both MBP and IL-I~ propeptide, but since there is no correlate of MBP in mammalian cells, this specificity is irrelevant. For production of anti-peptide antibodies, peptides corresponding to amino acids 1-27, 28-57, 58-87, and 88-116 of the IL-1B propeptide sequence were produced by the technique of Merrifield (20) using a peptide synthesizer from Applied Biosystems, Inc. (Model 430). Peptide-KLH conjugates were made by mixing peptide and KLH (Sigma Chemical Co., St. Louis, MO), both 0.5 mg/ml in 0.1 M NaHCO3/Na2CO3 buffer, pH 8.5, with 1.25% glutaraldehyde at 23~ for 48 h, followed by exhaustive dialysis against water, and then against PBS. Rabbits were immunized with 200/xg of individual peptide-KLH conjugates in CFA, followed by two boosters of conjugate in IFA. Only immunization with peptides 28-57 and 88-116 resulted in production of antibodies that were usable for Western blot and immunoprecipitation. IgG from rabbit antisera was prepared by adsorption to recombinant protein A-Sepharose 4B (Zymed Laboratories, Inc., South San Francisco, CA) and elution at neutral pH (ImmunoPure Gentle Ag/Ab Buffer System from Pierce, Rockford, IL), followed by exhaustive dialysis.
Western Blots. hrlL-1/~ was kindly donated by Upjohn Pharmaceuticals. Factor Xa digests of MBPqbl/5 propeptide were prepared as described above. Samples were electrophoresed on 14% acrylamide SDS gels and electrophoretically transferred to nitrocellulose membranes (Trans-blot System from Bio-Rad Laboratories, Hercules, CA). Prestained molecular weight markers (Bio-Rad Laboratories) were used. Blots were blocked overnight with 3% gelatin (Bio-Rad Laboratories) in TBS (20 raM Tris, 500 mM NaC1, pH 7.5), and then incubated with the indicated primary rabbit antibody in 1% gelatin-TTBS (TBS with 0.05% Tween-20), washed in TTBS, and incubated with 1/3,000 goat anti-rabbit IgG alkaline phosphatase conjugate (Bio-Rad Laboratories) in 1% gelatin-TTBS. Blots were then developed by adding substrate solution consisting of 132 #1 of p-nitroblue tetrazolium chloride (50 mg/ml in 70% dimetbylformamide) and 66/zl of 5-bromo-4-chloro-3-indolyl phosphate (50 mg/ml in dimetbylformamide) per 20 ml of 100 mM "Iris, 100 mM NaCI, 5 mM MgC12, pH 9.5.
Isolation and Biosynthetic Labeling of Human Monofftes. Leukocyterich plasma was prepared from peripheral blood of normal human volunteers by anticoagulation with 3 mM EDTA and removal of erythrocytes by 1 g sedimentation for 60 rain in 0.6% dextran. Monocytes were then separated from the remainder of the leukocytes by density gradient centrifugation on 1-Step Monocytes (Accurate Chemical & Scientific Corp., Westbury, NY), according to the manufacturer's directions. The calls obtained by this method were >99% monocytes by Wright stain and >98% viable by exclusion of 0.1% trypan blue. Monocytes were washed twice and suspended at 106 cells/ml in culture medium (methionine-free RPMI-1640 plus 2 mM L-glutamine, 100 U/m1 penicillin, 100 #g/m1 streptomycin, and 2% heat-inactivated autologous human serum). LPS (10 gg/ml) from E. coli serotype 055:B5 (Sigma Chemical Co.) and 100 #Ci/ml [3SS]methionine and [3SS]cysteine (Expre~SS3sS protdn labeling mix, >1,000 Ci/mmol, New England NuclearDuPont, Wilmington, DE) were added, and cells were cultured for 4 h at 37~ Virtually all the monocytes adhered to the tissue culture vessel.
For pulse-chase experiments, LPS-stimulated human monocytes were biosynthetically labeled as above, washed with culture medium containing unlabeled methionine, and cultured for an additional 4 h in culture medium containing unlabeled methionine and 10 #g/ml LPS. Replicate cultures were harvested at various intervals.
Immunoprecipitation of Culture Sut,ematants and Cell Lysates. After 4 h, culture supematant was collected and the adherent cells were washed once with fresh culture medium. The culture supematant and wash were pooled and centrifuged at 600g for 10 min at 4~ to remove any monocytes that may have become nonadberent. PMSF and benzamidine were added to achieve final concentrations of 1 and 25 mM, respectively, and the culture supematant was then centrifuged at 30,000 g for 30 rain at 4~ Adherent cells were lysed by addition of ice-cold lysis buffer (50 mM "Iris, 150 mM NaCI, 1 mM PMSF, 25 mM benzamidine, 1% NP-40, pH 7.5), followed by incubation at 4~ for 30 rain. Cell lysate was centrifuged at 30,000 g for 30 rain at 4~ Samples were stored overnight at -70~ quickly thawed at 37~ and chilled on ice. All subsequent immunoprecipitation and washing operations were carried out at 4~ In some experiments described but not shown, a mixture of five additional protease inhibitors was added to the culture supematants and cell lysis buffer (final concentrations 1 mM EDTA, 10 mM N-ethylmaldmide, 1 ttg/ml leupeptin, 1 #g/ml pepstatin, and 1 ttg/ml aprotinin).
Culture supernatants and cell lysates were cleared of IgG from the culture medium by tumbling with an excess amount (at least 100/A per 5 ml of sample) of recombinant protein G-Sepharose 4B beads (PGS) (Zymed Laboratories, Inc.). Samples were centrifuged at 50 g for 5 rain to remove the beads, and then divided into the desired number of equal aliquots. Supernatants and cell lysates representing equal numbers of cells, usually between 0.5 x 106 and 1 x 106, were used for immunoprecipitation with each different antibody. The IgG fractions of rabbit antisera, purchased or prepared as described above, were individually titered for use in immunoprecipitation.
For competition studies, a limiting amount of antibody was added. For all other studies, antibody was added in approximately fivefold excess of the amount needed to precipitate the maximal amount of radiolabeled Iblfl moieties. At fivefold excess, the effidency of immunoprecipitation for all the antibodies, determined by repeating the same immunoprecipitation on the supernatant from the first immunopredpitation, was between 80 and 85%. However, antibody against IL-lfl propeptide consistently precipitated more precursor Iblfl, on both the first and second immunoprecipitations, than did antibody against mature IL-1/3.
Each aliquot of culture supernatant or cell lysate was incubated for 1 h with the indicated antibody, and then tumbled for 90 min with 40/~1 of fresh PGS beads. The beads were collected by centrifugation at 50 g for 3 min and were washed three times with wash buffer A (10 mM Tris, 500 mM NaC1, 2 mM EDTA, 1 mM PMSF, 0.2% NP-40, pH 7.5), two times with wash buffer B (same as A but with 150 mM NaC1), and once with 10 mM Tris, 1 mM PMSF, pH 7.5, taking care not to lose beads when aspirating the wash solutions. The PGS was ehted twice with 40 gl of sample buffer for SDS-PAGE (19) for 10 rain at room temperature, and ehates were pooled and frozen overnight at -70~ SDS-PAGE and Detection of Labeled Proteins. The entire [3sS]-methionine-labded eluate from each immunoprecipitation was applied to 14% polyacrylamide SDS gels for electrophoresis. Molecular weight standards from Bio-Rad Laboratories were used. Gels were stained with Coomassie Blue, impregnated with fluor (En3Hance; New England Nudear-DuPont) according to manufacturer's directions, dried, and exposed to X-Omat AR film (Kodak, Rochester, NY) for the indicated times. For some experiments, gels were dried without impregnation with fluor and analyzed using a Molecular Dynamics Phosphorlmager, which allowed quantitation of bands but did not produce images acceptable for reproduction.
Results
Production and Enzymatic Cleavage of Fusion Protein. The recombinant fusion protein MBP-IL-lfl propeptide was expressed in large amounts in induced E. coli and rendered substantially free of contaminating bacterial proteins or degradation products by amylose affinity chromatography. A typical preparation, analyzed by SDS-PAGE and Coomassie Blue staining, is shown in Fig. 1 A. The heavy band migrating at approximately 60 kD in SDS-solubilized induced E. coli (lane 2) is the fusion protein, which is absent from uninduced bacteria (lane 1). This fusion protein was partially purified from bacterial extracts by selectively binding to amylose and during with maltose (lanes 3-I0) . Typical yields from this procedure were 3 to 6 mg of fusion protein per liter of induced E. coli suspension. As shown in Fig. 1 B, digestion of this product with Factor Xa produced maltose binding protein, migrating at ~38 kD, IL-lfl propeptide, migrating at '~17.5 kD, and some residual undigested fusion protein.
Although the apparent molecular weight of the IL-lfl propeptide was large~ than expected, its identity was verified by DNA sequencing of the expression vector (21) and amino acid sequencing of the first 10 NH2-terminal amino acid residues of the 17.5-kD band.
Specificity of Antibodies. The specificity of rabbit polyclonal antibodies produced against hrIL-lfl propeptide (amino acids 2-116), and against smaller synthetic peptides of this protein, was checked by Western blotting, as described in Materials and Methods and shown in 1 and 2) , MBP-IL-1B propeptide fusion protein (lanes 3 and 4), or IL-1B synthetic peptides (amino acids 28-57 and 88-116) (lanes 5 and 6) at 1/500 dilutions were used to probe this blot. The antigen in lanes 1, 3, and 5 was 100 ng of commercially obtained hrlIr (mature, amino acids 117-269) and in lanes 2, 4, and 6, 300 ng of Factor Xa digest of fusion protein (MBP-IL-1B propeptide amino acids 2-116) containing ,~100 ng of propeptide.
17.5-kD hrlL-lfl. The lowest prestained marker, lysozyme, is said to migrate at 18.5 kD (Bio-Rad Laboratories, package insert), but its migration is anomalous with respect to the known migration of mature IL-lfl, and with respect to unmodified molecular weight markers (not shown).
Detection of IL-I~ Propeptide from LPS-stimulated Human
Monocytes. Human peripheral blood monocytes were stimulated with LPS and biosynthetically labeled with [3SS]methionine-cysteine mix. Proteins recognized by antibody against mature IL-1/~, MBP-hrlL-1/3 propeptide, and IL-lfl synthetic peptides were isolated by immunoprecipitation. The entire sample from each immunoprecipitation was analyzed by SDS-PAGE and fluorography. As shown in Fig. 3 , the major intracellular precursor form of IL-lfl migrated at m35 kD. Multiple smaller bands between 29-35 kD were seen, comparable to other reports (11, 13) . Precursor I1-1/5 was also found, in smaller amounts, in culture media, mainly as the 35-kD form (lanes I-3) . In subsequent experiments (not shown), the amount of precursor in the culture media could be reduced, but not entirely eliminated, by more thorough removal of cells from the media before the second, high speed, centrifugation. Others have also demonstrated the apparent secretion of precursor IL-I~ (9, 11, 13, 14) . Mature 17.5-kD IL-1B was present largely as a secreted product (lane 3), although some was observed in cell lysates (lane 6). The apparent retention of a small amount of mature IL-1/3 intracellularly by human monocytes has been shown in previous reports (11, 13, 14) . An artifact, such as continued activity of ICE after cell lysis, or sticking of processed IL-1/3 to the plasma membrane before lysis, has not been entirely ruled out.
The observation unique to this report is that two proteins are recognized by specific antibodies against IL-I~ propep- 610 Interleukin 1B Propeptide tide and its smaller synthetic peptides (Fig. 3, lanes 1, 2, 4 , and 5). Based on the unusually slow migration of the 115-amino acid recombinant propeptide (Fig. 2) , the band with mobility virtually identical to that of mature 17.5-kD IL-13 ( Figs. 2 and 3 ) appears to be the naturally produced IL-lfl propeptide. A second band migrating at ,v 14 kD, also immunoprecipitated by the anti-propeptide antibodies, is evident in Figs. 3 and 4. As shown in Fig. 4 , antibody against amino acids 28-57, and antibody against amino acids 88-116 of the propeptide sequence, both precipitate this band in approximately equal amounts. The presence of epitopes from these two noncontiguous portions of the precursor suggests that this protein may be a result of cleavage near the amino terminus of the 17.5-kD propeptide. This 14-kD protein may result from further processing of the propeptide at a second site, Asp27-Gly 2s, characterized previously using highly purified ICE and synthetic peptides (22) . As shown in Fig. 3 , the IL-1/3 propeptide moieties were found both extracellularly (lanes 1 and 2) and intracellularly (lanes 4 and 5). The relative proportions of the 17.5-and 14-kD propeptide moieties varied somewhat among monocytes from several individual donors, but was consistent for each individual in separate experiments. In general, however, 
Competition by Unlabeled Mature IL-1fl and MBP-IL-I~
Propeptide. Although specificity of the antibodies used for these experiments was demonstrated by Western blot, we wished to demonstrate that they were specific for the relevant native, as well as denatured, proteins. For the experiment shown in Fig. 5 , biosynthetically labeled culture supernatant from LPS-stimulated monocytes was divided into equal aliquots, which then received either no addition, unlabeled hrlL-lfl (mature IL-I~), or unlabeled MBP-IL-lfl propeptide. Limiting quantities of antibody against either mature I1-18 or I1-18 propeptide were added, and immunoprecipitation was carried out as usual. As expected, unlabeled mature IL-13 (lane 5), but not unlabeled MBP-IL-13 propeptide (lane 6), competed for binding of labeled mature IL-13 and precursor IL-13 to anti-mature I1-18. Conversely, unlabeled MBP-IL-13 propeptide (lane 3) but not unlabeled mature IL-13 (lane 2) competed for binding of labeled IL-13 propeptide and precursor IL-13 to antibody against IL-13 propeptide. In experiments not shown, unlabeled recombinant MBP did not compete out any of the IL-13 bands. Therefore, the 17.5-and 14-kD bands immunoprecipitated with antibodies against IL-13 propeptide are not related to mature IL-13, and represent authentic IL-13 propeptide moieties. In the experiment shown, mainly the 14-kD IL-13 propeptide was found in the culture supernatant. Longer exposure (not shown) was required to detect the 17.5-kD propeptide, which was competed out as described above.
The decreased ability of anti-mature IL-13 to immunoprecipitate the 35-kD precursor IL-13 was especially notice- 1-3) and anti-mature IblB (lanes 4-6). Samples were analyzed by SDS-PAGE and fluorography. This gd was exposed to film for 3 wk.
611
Higgins et al. 3 and 7-9 ) or anti-mature Ibl/3 (lanes 4-6 and 10-12). Immunoprecipitates were analyzed by SDS-PAGE and fluorography. This gel was exposed to film for 1 wk.
able at limiting antibody dilutions (in Fig. 5 , compare lanes 1 and 2 to lanes 4 and 6). This may reflect a low affinity of anti-mature IL-I~ antibodies for precursor IL-1B, as has been noted previously (12, 13) . A band of "~43 kD was found in immunoprecipitates of culture supernatants and, to a much lesser extent, cell lysates. This band appeared with all the antibodies used, and was not competed out by unlabeled mature IL-1/3 or MBP-IL-1B propeptide (Fig. 5) , suggesting that this protein binds nonspecifically to antibodies. This unexplained 43-kD band is also evident in previous reports of IL-I~ processing (9, 10, 14) .
Accumulation of lL-lfl Propeptide in Culture Medium and Cell
Lysates. To follow the course of precursor IL-I~ processing and production of propeptide moieties, pulse-chase experiments were conducted. As shown in Fig. 6 , both the predominant 14-kD IL-1/~ propeptide and the 17.5-kD propeptide accumulate in culture medium over time (lanes 1-3) . As demonstrated by others (11, 13, 14) , mature IL-I~ also accumulates in culture medium (lanes [4] [5] [6] . Smaller amounts of propeptides and mature IL-I~ are also seen in cell lysates. Intracellularly, the 35-kD precursor appears to remain relatively constant (better seen on shorter exposures) but precursors of '~29-and 31-kD decrease. The results do not distinguish which size of precursor IL-1/3 gives rise to mature IL-1/3 and IL-1B propeptide, and may reflect a complex relationship between precursors and products.
Discussion
We report here the synthesis of recombinant human IL-1B propeptide (Ala2-Asp116), the production of antibodies which specifically react with this propeptide, and the immunoprecipitation by these antibodies of two unique proteins from human monocytes stimulated to synthesize and process precursor IL-I~. The larger of these two proteins migrates on SDS-PAGE with a mobility almost identical to that of mature 17.5-kD IL-I~, but is dearly not mature IL-I~ because the specific antibody does not bind mature IL-I~. This protein is almost certainly bona fide IL-1B propeptide, the NH2-terminal product of the ICE which cleaves prolL-l~ between Asp 116 and Ala 117. To our knowledge, this is the first demonstration of the existence of the intact IL-1B propeptide in vitro.
Schmidt and Bomford (9) did identify an 18-kD biosynthetically labeled protein from stimulated monocytes, using antibodies against amino acids 1-15 of precursor IL-1/3. However, since antibodies against other short synthetic peptides from the NH2-terminal region (amino acids 17-32, 43-54, and 89-100) failed to detect this protein, they concluded that it was not derived from the NH2 terminus of precursor IL-1/3. It is possible that antibodies against most of the 15-amino acid synthetic peptides failed to react with intact IL-1/3 propeptide because of conformational differences. The peptides used successfully in the present study for production of anti-IL-1~/propeptide antibodies were nearly twice as long as those described above. Other studies (10) (11) (12) (13) (14) of IL-1B processing have not been designed to address the fate of the IL-13 propeptide because only antibodies against mature IL-13 were used.
A second protein of'~ 14 kD is also detected by antibodies against recombinant IL-1B propeptide, and by antibodies against synthetic peptide fragments 28-57 or 88-116. The simplest explanation for this smaller propeptide moiety is that it lacks some of the NH2-terminal residues of the 17.5-kD propeptide. This is an especially attractive explanation, since precursor IL-1B contains a second site for cleavage by ICE, at Asp27-Gly 2s (22) . Thus, the 14-kD moiety may represent the Gly2S-Asp 116 fragment of the IL-1B propeptide. Since immunization with the synthetic peptide 1-27 did not result in the production of antibodies useful for immunoprecipitation, we have not further tested this hypothesis.
The recombinant IL-13 propeptide (amino adds 2-116) migrates more slowly on SDS-PAGE than would be expected for a 115-amino acid protein. The monocyte-derived propeptide, demonstrated by biosynthetic labeling and immunoprecipitation, migrates slightly more slowly than its recombinant counterpart, which could possibly be accounted for by posttranslational modifications. The NH2-terminal portion of the intact precursor IL-1B is myristoylated (23), but is not glycosylated (11) .
The 17.5-and 14-kD propeptide moieties do not appear to be the result of nonspecific or artifactual cleavage of precursor IL-I~ by proteases, other than ICE, found in the culture medium or released during lysis of cells. Inclusion of five additional protease inhibitors (see Materials and Methods) in the harvested culture medium and the cell lysis buffer did not result in immunoprecipitation of less mature IL-1B or propeptide moieties (experiments not shown). It is also unlikely that the 17.5-and 14-kD propeptide moieties are a result of toxic cell damage from the high concentration of LPS used in these experiments. In separate experiments (not shown), both mature IL-1/3 and IL-1B propeptide increased in culture supernatants with increasing concentrations of LPS from 1 ng/ml through 10 #g/ml, while the amount of intracdlular precursor was already maximum at 1 ng/ml LPS. Furthermore, increasing concentrations of LPS did not result in increasing amounts of precursor IL-1/3 being released into the supernatant, which could be a marker for cell damage.
The band intensities of IL-I~ propeptide moieties which are detected at the end of 4 h of biosynthetic labeling, or which accumulate during a chase, seem to be less than would be expected if the propeptide(s) persists in a 1:1 relationship with mature IL-1/~. The fluorographic technique used here tends to underestimate proteins which contain less radiolabel or are present in smaller amounts (24) . Therefore, separate experiments were performed for the purpose of estimating the relative amounts of precursors and products. Using a Phosphorlmager, the relative band volumes of intracellular 35-kD precursor to extracellular mature IL-1B to extracellular 14-kD propeptide were roughly 100:10:1. Correcting for methionine content (11:6:3, respectively) results in an approximate molar ratio of 27:5:1. Since IL-I~ propeptide(s) should be initially produced in 1:1 relationship with mature IL-/3, it appears that the propeptide moieties are degraded faster than mature IL-1B. However, the observation that radiolabeled 17.5 kD and 14 kD IL-1{3 propeptide moieties do accumulate in pulse-chase experiments does suggest that a pool of IL-1/3 propeptide may exist in vivo.
These results lead us to speculate that the NHrterminal portion of precursor IL-1/3 serves functions other than rendering the precursor inactive. The precedent is established in vertebrate biology for two or more portions of a cleaved precursor protein to serve different roles. For example, complement components C3 and C5 are cleaved to form C3a and C3b, C5a and C5b, which have different effector roles in the complement cascade (25) ; procollagen is cleaved to form structural collagen, and noncollagenous carboxypeptide and aminopeptide fragments which modulate collagen synthesis (26, 27) ; and pro-opiomdanocortin is cleaved to form several peptide hormones (28) . The apparent distribution of IL-1B propeptide moieties in both the intraceUular and extracellular compartments raises interesting hypotheses concerning possible roles in regulating the processing of IL-1B, modulating the activity of mature IL-1/$, or functioning as an independent cytokine. The recent discovery that overexpression of ICE induces apoptosis in fibroblast call line (29) suggests the exciting possibility that the IL-1/3 propeptide could play a role in programmed death of monocytes. The ability to produce reasonable quantities of purified recombinant propeptide should allow investigation of these possibilities.
